Antibody Purification Using Membrane Adsorbers - Results from a process developed for a commercial antibody. - BioPharm International

ADVERTISEMENT

Antibody Purification Using Membrane Adsorbers
Results from a process developed for a commercial antibody.


BioPharm International
Volume 21, Issue 12

REFERENCES

1. Daemmrich A, Browden ME. A rising drug industry. Chem Eng News. 2005;Jun:28–42.

2. Gottschalk U. New and unknown challenges facing biomanufacturing. BioPharm Int. 2005; 18(3):24–28.

3. Thoemmes J, Kula MR. Membrane chromatography. An integrative concept in the downstream processing of proteins. Biotechnol Prog. 1995;11:357–367.

4. Zhou J, Tressel T. Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol Prog. 2006;22:341–349.

5. Etzel M, Riordan W. Membrane chromatography: Analysis of breakthrough curves and viral clearance. In: Shukla A, Etzel M, Gadam S, editors. Process Scale Bioseparations for the Biopharmaceutical Industry. Boca Raton, FL:Taylor & Francis;2006.

6. Walter JK. Strategies and considerations for advanced economy in downstream processing of biopharmaceutical proteins. In: Subramanian G, editor. Bioseparation and bioprocessing. processing, quality and characterization, economics, safety and hygiene. New York: Wiley VCH; 1998. p. 447–460.

7. Gebauer KH, Thömmes J. Kula MR. Breakthrough performance of high-capacity membrane adsorbers in protein chromatography. Chem. Eng Sci. 1997;52:405–419.

8. Gottschalk U. Bioseparation in antibody manufacturing: The good, the bad and the ugly. Biotechnol Prog. 2008 (in press).

9. Norling L, et al. Impact of multiple reuse of anion exchange chromatography media on virus removal. J Chromatogr. 2005;1069:79–89.

10. Zhou JX, et al. New Q membrane scale-down model for process-scale antibody purification. J Chromatogr A. 2006;1134,66–73.

11. Marlind J, et al. Clin Cancer Res. 2008 Oct 15;14(20):6515-24.

12. Zhou J, Tressel T. Q membrane chromatography as a robust purification unit for large-scale antibody production. BioProcess Intl. 2005;3(suppl):32–37.

13. Kelley B. Very large scale monoclonal antibody purification: the case for conventional unit operations. Biotechnol Prog. 2007;23:995–1008.

14. Curling J, Gottschalk U. Process chromatography: Five decades of innovation. BioPharm Int. 2007;20:10–19.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

New Tax Rules May Deter Future Pharma M&A
October 1, 2014
NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
Author Guidelines
Source: BioPharm International,
Click here